2004 Press Releases

• William Haseltine Joins OneWorld Health Board of Directors 12.16.04
• $42.6 Million Five-Year Grant from Gates Foundation for Antimalarial Drug Brings Together Unique Collaboration of Biotech, Academia, and Nonprofit Pharma 12.14.04
• OneWorld Health Honored By Scientific American as 2004 Business Leader in Public Health 11.8.04
• OneWorld Health Presents Preliminary India Clinical Trial Results at ASTMH 11.1.04
• Institute for OneWorld Health Adds Board Member, Senior Staff to Support International Progress in Drug Development Programs 9.28.04
• Institute for OneWorld Health to Compile Comprehensive State of Infectious Diarrhea Treatments and Potential Solutions 8.23.04
• Institute for OneWorld Health Nominated for the 2004 World Technology Awards 8.16.04
• Chiron Foundation Awards Grant to Support Disease Surveillance Program in India 8.10.04
• Institute for OneWorld Health Receives Gates Foundation Grant to Fund Development of Malaria Vaccine 7.13.04
• Institute for OneWorld Health Completes Patient Enrollment, Treatment in India for Largest Phase III Clinical Trial for Visceral Leishmaniasis (Kala Azar) 5.18.04
• CEO of Institute for OneWorld Health Advocates Focus First On Developing World Markets 5.10.04
• Institute for OneWorld Health Announces Plans to Form Network of Volunteer Pharmaceutical Scientists for Global Health 3.29.04
• Institute for OneWorld Health Earns Achievement Award and Spot on Panel at Renowned Philanthropic Conference 3.3.04
• Donation of UC Santa Barbara Discovery to Institute for OneWorld Health May Accelerate New Treatment for Global Health Problem 2.23.04
• OneWorld Health Names New Board Member 2.16.04
• CEO Hale Speaks at Davos World Economic Forum 1.25.04

RSS Feed